Community Burden of MG Infection
- Conditions
- Sexually Transmitted Infection (STI)Mycoplasma Genitalium Infection
- Registration Number
- NCT06793605
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
Objective: To assess the burden and the transmission dynamics of Mycoplasma genitalium (MG) infection in men who have sex with men in Hong Kong.
Design and setting: involving a) a cross-sectional study (completion of an online self-administered survey, followed by self-sampling for testing in the laboratory, and performance of HIV self-test); b) a mathematical modelling study to simulate the transmission dynamics of MG infection and resistant MG infection and compare the impacts of test-and-treat strategies.
Participants: Around 920 men who have sex with men would be recruited
- Detailed Description
Cross-sectional study: A total of 920 men who have sex with men aged 18 or above and normally living in Hong Kong would be recruited. Eligible participants would be asked to complete a self-administered online survey, submit self-collected urine specimen and rectal swabs for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium testing in the laboratory, and submit HIV self-test results.
Mathematical modelling study: A compartmental model would be constructed to simulate the transmission dynamics of MG infection and resistant MG infection, and analyse the impact of different test-and-treat strategies.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 920
- men who have sex with men aged 18 or above, normally living in Hong Kong, and could communicate in written and spoken English or Chinese
- cannot provide consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of MG infection 1 year detection of MG infections in self-collected samples divided by the total number of samples collected
prevalence of MG resistance mutations 1 year detection of MG resistance mutations macrolide/fluoroquinolone in MG positive samples divided by the total number of MG positive samples
- Secondary Outcome Measures
Name Time Method prevalence of CT infection 1 year detection of CT infections in self-collected samples divided by the total number of samples collected
prevalence of NG infection 1 year detection of NG infections in self-collected samples divided by the total number of samples collected
co-infection of STIs 1 year number of co-infection of HIV, CT, NG, and/or MG
history of STI and HIV testing ever number of self-reported history of STI and/or HIV testing at survey
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
The Chinese University of Hong Kong
🇭🇰Hong Kong, Hong Kong